Screener
Enliven Therapeutics ELVN PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Enliven Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Enliven Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211982
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Marketable securities | 320,217 | 363,725 |
| Prepaid expenses and other current assets | 10,736 | 12,257 |
| Total current assets | 463,137 | 474,878 |
| Property and equipment, net | 20 | 34 |
| Operating lease right-of-use assets | 290 | 383 |
| Deferred offering costs | 217 | 217 |
| Other long-term assets | 1,188 | 656 |
| Total assets | $464,852 | $476,168 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Enliven Therapeutics's PP&E (net)?
- Enliven Therapeutics (ELVN) reported PP&E (net) of $20K in Q1 2026.
- How has Enliven Therapeutics's PP&E (net) changed year-over-year?
- Enliven Therapeutics's PP&E (net) decreased by 95.0% year-over-year, from $404K to $20K.
- What is the long-term trend for Enliven Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Enliven Therapeutics's PP&E (net) has grown at a -37.2% compound annual growth rate (CAGR), from $349K to $34K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Enliven Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude